TECH vs VKTX · P/E 65, rev $1.22B vs $3.97B cap
Bio-Techne Corp (TECH) versus Viking Therapeutics Inc (VKTX) — a side-by-side from cached financials, not a winner call.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Viking Therapeutics Inc (VKTX) is a biotechnology company listed on US.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Latest reported VKTX revenue for 2025-12-31 was $0. Net income was -$359.6M. VKTX currently screens at market cap $3.97B.
TECH currently screens at market cap $8.49B and trailing P/E 65.2. VKTX currently screens at market cap $3.97B.
Not investment advice. Open the TECH and VKTX stock pages for the full models.
Not investment advice.